PAPP-A in cardiac and non-cardiac conditions

Yuehua Li1, Chenghui Zhou, Xianliang Zhou

  • 1State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100037, China.

Insights

Pregnancy-associated plasma protein-A (PAPP-A) is a biomarker for heart disease and aging. It plays a role in atherosclerosis and may be a target for anti-aging therapies, impacting lifespan.

Area of Science:

  • Biochemistry
  • Cardiology
  • Gerontology

Background:

  • Pregnancy-associated plasma protein-A (PAPP-A) is a protease in the insulin-like growth factor (IGF) axis.
  • PAPP-A cleaves IGF binding proteins, releasing IGFs and influencing cellular processes.
  • It has emerged as a significant biomarker in various medical conditions.

Purpose of the Study:

  • To review the role of PAPP-A in cardiac and non-cardiac conditions.
  • To highlight PAPP-A's potential as a diagnostic biomarker and therapeutic target.
  • To explore PAPP-A's association with aging and disease progression.

Main Methods:

  • Literature review of studies on PAPP-A.
  • Analysis of PAPP-A's enzymatic function and biomarker utility.
  • Examination of PAPP-A's role in atherosclerosis, aging, and disease.

Main Results:

  • PAPP-A is crucial in progressive atherosclerosis and a biomarker for acute coronary syndrome.
  • It predicts all-cause mortality and cardiovascular events.
  • PAPP-A knockout mice exhibit extended lifespans, suggesting an anti-aging role.
  • PAPP-A is also linked to malignant cancer and end-stage renal disease.

Conclusions:

  • PAPP-A is a versatile biomarker with implications for cardiovascular health and aging.
  • Its role as a protease and its association with diverse diseases warrant further investigation.
  • PAPP-A presents a potential target for therapeutic interventions in aging and disease.

Related Concept Videos

Cardiovascular System Abnormal Findings I: Inspection and Palpation01:29

Cardiovascular System Abnormal Findings I: Inspection and Palpation

In a cardiovascular examination, inspection and palpation are crucial for identifying abnormalities.
Abnormal findings observed during an inspection
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...